Buy Retatrutide Dubai: Price, COA & Delivery

What Is Retatrutide?

Retatrutide (LY-3437943) is a triple-agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon receptor). This three-receptor mechanism distinguishes it from single-agonist compounds like semaglutide and dual-agonist compounds like tirzepatide.

In a Phase 2 trial published in the New England Journal of Medicine, retatrutide demonstrated a 24.2% mean body weight reduction at the highest dose over 48 weeks. The pivotal Phase 3 TRIUMPH-1 obesity trial reported positive topline results on May 21, 2026: 28.3% mean weight loss at 80 weeks on 12 mg (up to 30.3% at 104 weeks in a BMI ≥35 extension). Eli Lilly’s broader TRIUMPH and TRANSCEND programmes continue to generate readouts, and Lilly has not publicly announced an NDA filing date as of May 28, 2026. For a detailed regulatory timeline, see our retatrutide approval status tracker; for Dubai market context, see Retatrutide Dubai.

All retatrutide materials supplied by Remy Peptides are strictly for in-vitro laboratory research and are not intended for human or veterinary administration. This guide is about supplier evaluation and research-use procurement, not medical dosing or treatment.

Retatrutide Product Formats Available in Dubai

Two prefilled pen formats are currently in active Dubai supply. The 30mg pen is the flagship for multi-week titration protocols; the 20mg pen is suited to shorter studies where upfront cost is the primary constraint. Both are Janoshik-verified, dispatched cold-chain, and supplied strictly for in-vitro laboratory research. For the full six-format catalogue, compare the Retatrutide UAE format matrix.

UAE Regulatory Landscape for Research Peptides

Understanding the regulatory framework is essential before sourcing any research compound in the UAE. Retatrutide occupies a specific position within this framework that researchers should be aware of.

Under MoHAP Circular 17/2022, research-grade peptides that are clearly labelled for in-vitro laboratory use and are not marketed for human consumption operate within the existing regulatory framework. Retatrutide is not classified as a controlled substance in any UAE jurisdiction. As an investigational compound without regulatory approval from the FDA or any other authority, it falls outside the scope of scheduled pharmaceutical regulations.

This is distinct from approved prescription GLP-1 medications like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro), which are regulated pharmaceuticals available only through licensed pharmacies with a prescription. Retatrutide will not be available through clinical channels until after FDA approval and subsequent MoHAP regulatory review.

The requirement is that all materials carry “For Research Use Only” labelling and that no therapeutic claims are made. For a broader overview of peptide legality across jurisdictions, see our peptide legality guide, our Dubai-specific legality brief, our peptides in the UAE overview, and the UAE, GCC and Lebanon guide hub if the search has regional intent beyond Dubai.

If you need the molecule-level routing layer before screening suppliers, open the Retatrutide Research Hub. It separates mechanism, approval status, dosing, Dubai availability, and trial milestones so this checklist can stay focused on proof and supplier quality.

What to Look for in a Retatrutide Supplier

Not all peptide suppliers maintain equivalent quality standards. The following criteria separate verified research-grade sources from unreliable ones. Applying this checklist before placing any order protects both research integrity and laboratory budgets.

Third-Party Purity Testing

The single most important indicator of a legitimate supplier is independent purity verification. Demand HPLC (High-Performance Liquid Chromatography) analysis conducted by a third-party laboratory — not an in-house test. A minimum threshold of 99% purity is standard for research-grade retatrutide. Remy Peptides uses Janoshik Analytical, an independent Czech laboratory widely recognised in the peptide research community, and publishes full test results for each released Retatrutide batch.

Certificate of Analysis

A genuine COA is batch-specific, dated, and includes quantitative HPLC data with retention times and peak area percentages. Generic specification sheets or undated documents are insufficient. Every Remy Peptides batch COA is published at /coa/ with the batch number, test date, and complete analytical results. Batch RETP002 is verified at 99.262% purity. For a field-by-field reading of HPLC purity, assay, LC-MS identity, endotoxin, TFA, and heavy metals, use the Peptide COA Guide.

Format and Delivery

Retatrutide is available in three formats: prefilled pen, lyophilised powder vial, and raw powder. For laboratory research requiring precise dosing, prefilled pens eliminate reconstitution errors and contamination risk. In Dubai’s climate — where summer temperatures regularly exceed 45°C — tracked cold-chain delivery is not optional. Insulated, temperature-monitored packaging is essential to preserve peptide integrity from dispatch to laboratory receipt. For a complete breakdown of pen mechanics and dosing protocols, see our retatrutide pen guide.

Pricing Transparency

Reputable suppliers publish pricing in local currency (AED) without hidden fees for shipping, cold-chain packaging, or COA documentation. Volume discounts should be clearly tiered. Any supplier that cannot provide upfront pricing or requires negotiation before revealing costs warrants caution.

Prefilled Pen vs Vial: Which Format for Dubai Research?

Format selection directly impacts dosing accuracy, contamination risk, and workflow efficiency in the laboratory. The following comparison covers the key variables researchers should evaluate.

For most Dubai-based research protocols, the prefilled pen format offers superior dosing reproducibility and eliminates the primary contamination vector associated with powder reconstitution. The sealed pen system also provides better thermal stability during last-mile delivery — a significant consideration in the UAE climate.

For detailed guidance on pen mechanics and click-based titration, see our retatrutide pen guide. For storage protocols across all formats, see our peptide stability and storage guide.

Retatrutide vs Mounjaro, Wegovy, and Other GLP-1 Options

The key differentiator for retatrutide is its triple-receptor mechanism. Approved GLP-1 therapies and next-generation compounds vary in the number of metabolic receptors they engage, which directly correlates with observed efficacy in published trials.

• Semaglutide (Ozempic in Dubai / Wegovy): Single receptor (GLP-1 only) — ~15% body weight reduction in trials
• Tirzepatide (Mounjaro in Dubai): Dual receptor (GLP-1 + GIP) — ~22.5% body weight reduction in trials
• Retatrutide: Triple receptor (GLP-1 + GIP + glucagon) — 24.2% body weight reduction in Phase 2 data; TRIUMPH-1 Phase 3 topline: 28.3% at 80 weeks (12 mg, May 21, 2026)

The addition of glucagon receptor agonism is the trial-reported driver of incremental efficacy over dual-agonist compounds. For a full breakdown including dosing schedules and mechanism analysis, see our Retatrutide vs Tirzepatide vs CagriSema comparison.

Retatrutide Pricing in Dubai

Remy Peptides publishes transparent AED pricing across three volume tiers for the 30mg and 20mg prefilled pen formats. Start with price context, then use the supplier-verification checks below before treating any quote as reliable.

• 30mg pen: AED 1,600 single, AED 1,450/pen at 2-pack, AED 1,300/pen at 5+ pack
• 20mg pen: AED 1,200 single, AED 1,100/pen at 2-pack, AED 1,000/pen at 5+ pack

Volume-tier pricing at Remy Peptides reduces the effective per-milligram cost on the 30mg pen — AED 1,600 (AED 53/mg) for a single pen, AED 2,900 (AED 48/mg) at the 2-pack tier, and AED 6,500 (AED 43/mg) at the 5+ tier. The 20mg pen runs AED 60/mg single, AED 55/mg at 2-pack, and AED 50/mg at 5+ pack. This provides verified cost-per-milligram transparency for HPLC-tested retatrutide in the UAE market.

Promotional bundle pricing is inactive. Compare prices using only the units listed in the paid tiers above.

Red flag: Prices significantly below AED 1,400 per 30mg pen should trigger due diligence. Sub-market pricing typically indicates compromised purity, lack of third-party testing, or substituted compounds. Always request a batch-specific COA before purchasing from any supplier.

Use this page as the guide layer, then verify live product details in the Retatrutide UAE pricing matrix, Retatrutide 30mg Pen page, and Retatrutide 20mg Pen page.

Dubai Cost per Milligram

For laboratories running multi-week protocols, the total cost per milligram is often more relevant than the per-pen price. Volume tiers reduce the effective per-mg figure rather than just the unit price, which matters once a study spans multiple titration steps.

• Single pen order: AED 1,600 for 30mg — AED 53/mg
• 2-pack order: AED 2,900 for 60mg — AED 48/mg
• 5+ pack order: AED 6,500 for 150mg — AED 43/mg

The volume-tier structure is designed to support sustained research protocols — particularly the 24-week and 48-week titration schedules modelled on the TRIUMPH clinical trial design — without requiring repeated single-unit procurement at premium rates.

Dubai and UAE Delivery Windows for Research Orders

All retatrutide orders dispatch from the Remy Peptides Dubai facility in insulated cold-chain packaging. Delivery windows vary by emirate, with Dubai offering same-day arrival when the order is confirmed before the cutoff.

• Dubai: Same-day delivery (order by 4 PM) — DIFC, Downtown, JBR, JLT, Business Bay, Dubai Marina, Dubai Hills
• Abu Dhabi: Next-day delivery
• Sharjah: Next-day delivery
• Ajman: Next-day delivery
• Other emirates: Next-day delivery — Ras Al Khaimah, Umm Al Quwain, Fujairah

Insulated, temperature-monitored packaging is critical when UAE summer ambient temperatures exceed 45°C. Cold-chain integrity from dispatch to laboratory receipt is the documented Remy Peptides standard regardless of order size or destination emirate.

Procurement Verification Steps for Dubai Research

Once a supplier passes the screen above, a research procurement workflow stays compliance-first. The sequence below is structured around verification rather than transaction speed.

1. Confirm research-only labelling: All retatrutide materials must carry “For Research Use Only” labelling consistent with MoHAP Circular 17/2022. No therapeutic, dosing, or clinical claims should appear on packaging or supplier copy.
2. Match the COA to the unit: Cross-reference the batch number on the pen or vial against the published COA before agreeing to any pricing. Remy Peptides publishes each released Retatrutide batch at /coa/.
3. Choose the format that fits the protocol: Review the retatrutide pen guide and stability and storage guide before fixing pack size. Live tiers and dispatch windows are listed on the Dubai price and delivery reference.
4. Calculate price from paid units only: Use AED 53/mg single, AED 48/mg at 2-pack, and AED 43/mg at 5+ pack for 30mg pens.
5. Confirm cold-chain handling: Dubai summer ambient temperatures regularly exceed 45°C. Insulated, temperature-monitored packaging with same-day Dubai or next-day inter-emirate dispatch is the documented Remy Peptides standard. Abu Dhabi and Sharjah use next-day cold-chain dispatch.
6. Open a verification channel: Use /contact-verify/ for documentation requests, institutional procurement, or batch questions before any payment is discussed.

Material is supplied strictly for in-vitro laboratory research. For a single consolidated view of Retatrutide UAE supply across all emirates, use the UAE supply reference.

How to Use This Buying Guide

Use the guide in this order: start with price, confirm the COA, check the format, then move to delivery and official contact verification. The linked Remy pages are evidence sources, not shortcuts around the verification steps.

1. Start with the price table: Compare the 30mg and 20mg pen tiers above, then cross-check the full six-format matrix at Retatrutide UAE pricing.
2. Open the batch proof: Match the product format to the correct report in the COA library, especially RETP002 for the 30mg pen and RET-20-C-2604-001 for the 20mg pen.
3. Check format math: Use the calculator, pen guide, and clicks guide before deciding which paid tier fits the research protocol.
4. Verify the official route: Use contact verification before sending funds, then use the relevant product page or order page only after the checks above are complete.